Skip to main content
Clinical Trials/NCT04715854
NCT04715854UnknownNot Applicable

Comparison of the Addition of an Aerosol Mask Above Nasal Canula on Oxygenation in Hypoxemic Failure

Laboratory of Movement, Condorcet, Tournai, Belgium2 sites in 1 country15 target enrollmentStarted: February 19, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
15
Locations
2
Primary Endpoint
Change in PaO2 and PaCO2

Study Overview

Brief Summary

This study will compare the impact of a classical aerosol mask above low-flow nasal cannula on the arterial oxygen tension in patients with COVID-19.

Detailed Description

Hospitalized patients with COVID-19 typically present with hypoxemia. In some patients, hypoxemia can be corrected with low flow nasal cannula. When placed above nasal cannula, some systems have demonstrated their interest in improving the performance of the patient's oxygen delivery. For example, two recent studies have shown that adding a Double-Trunk Mask (DTM) or Surgical Mask (SM) above nasal cannula has the potential to improve the PaO2 despite no change in oxygen output (1, 2) . However, no study has compared the effect on PaO2, of the addition of a classical aerosol mask above nasal canula.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Hypercapnia

Outcomes

Primary Outcomes

Change in PaO2 and PaCO2

Time Frame: 30 minutes

Changes in PaO2 \[ Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system \] Oxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system

Secondary Outcomes

  • Respiratory frequency(1 minute)

Investigators

Sponsor
Laboratory of Movement, Condorcet, Tournai, Belgium
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

frédéric Duprez

Deputy director, clinician, laboratory of movement Condorcet Belgium

Laboratory of Movement, Condorcet, Tournai, Belgium

Study Sites (2)

Loading locations...

Similar Trials